Life Sciences Virtual Investor Forum Agenda Announced for September 19th

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Life Sciences Virtual Investor Forum to be held September 19^th. This event is co-sponsored by Zacks Small-Cap Research

Individual investors, institutional investors, advisors, and analysts are invited to attend.

REGISTER NOW AT: https://bit.ly/3XnsBlt

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule 1x1 meetings with management.

“We’re looking forward to bringing the latest innovators together at the Life Sciences Virtual Investor Forum this Thursday,” said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. “In collaboration with Zacks Small-Cap Research, this conference will provide an efficient platform for these companies to seamlessly engage their investor base.”

September 19^th

Eastern Time (ET)	Presentation	Ticker(s)
9:30 AM	VolitionRX Limited	NYSE American: VNRX
10:00 AM	Genflow Biosciences Plc	OTCQB: GENFF | LSE: GENF
10:30 AM	Aprea Therapeutics, Inc.	Nasdaq: APRE
11:00 AM	Chromocell Therapeutics Corp.	NYSE American: CHRO
11:30 AM	BioVaxys Technology Corp.	OTCQB: BVAXF | CSE: BIOV
12:00 PM	Protalix BioTherapeutics, Inc.	NYSE American: PLX
12:30 PM	Acasti Pharma Inc.	Nasdaq: ACST
1:00 PM	Brainstorm Cell Therapeutics Inc.	Nasdaq: BCLI
1:30 PM	Aethlon Medical, Inc.	Nasdaq: AEMD
2:00 PM	Unicycive Therapeutics, Inc.	Nasdaq: UNCY
2:30 PM	Evaxion Biotech A/S	Nasdaq: EVAX
3:00 PM	Adaptimmune Therapeutics plc	Nasdaq: ADAP

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences^®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Media Contact: 
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com